Approval · Notice of Compliance 15948 · 2014
ACT NABILONE: Notice of Compliance 15948
Issued August 14, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 15948
- Date
- August 14, 2014
- Company
- Actavis Pharma CompanyToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Manufacturer and product name change
- Therapeutic class
- Antiemetic
- Canadian reference product
- CASAMET (Valeant Canada Lp)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ACT NABILONE | 02393581 | Cancelled Post Market |
| ACT NABILONE | 02393603 | Cancelled Post Market |